Search

Michele Mutti and colleagues at BioNTech discovered that the activity of anti-staphylococcal phages is severely impaired in plasma or synovial fluid, hindering their potential as an alternative treatment for S. aureus infections inside the

We are urgently seeking Pseudomonas aeruginosa and Staphylococcus aureus (MSSA) phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testin

Status unconfirmed. Checked 2026-10-03. This study will evaluate a topical bacteriophage therapy product (BACTELIDE) as an adjunct to standard therapy for the prevention and treatment of pressure ulcers colonized with S. aureus, P. aerugino

Completed. Checked 2026-10-03. Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic T

Ended. Checked 2026-10-03. Pilot non comparative study assessing the clinical control of infection of DAIR + SAT +NaCl and DAIR + SAT + Phages anti-Staphylococcus aureus in patients with Staphylococcus aureus Prosthetic Joint Infection with

Status unconfirmed. Checked 2026-10-03. DUOFAG® is a phage cocktail containing bacteriophages active against Staphylococcus aureus and Pseudomonas aeruginosa. It is an investigational medicinal product for the treatment of surgical site inf